Jack Yongfeng Zhang is a distinguished leader in the pharmaceutical industry, currently serving as the Chief Executive Officer, President, Chief Scientific Officer, and Director at Amphastar Pharmaceuticals Inc. With a robust background in both science and business, Zhang has been instrumental in guiding Amphastar to become a key player in the development and manufacture of high-quality, affordable generic and proprietary injectable, inhalation, and intranasal products. His journey with Amphastar began in the early stages of the company, where he has consistently demonstrated his commitment to innovation and excellence in pharmaceutical solutions. Zhang's professional journey is marked by significant achievements that underscore his expertise and leadership. Holding a Ph.D. in organic chemistry from the University of California, San Diego, Zhang's scientific acumen is complemented by his strategic vision for the company. Under his leadership, Amphastar has successfully expanded its product portfolio and strengthened its market presence, achieving notable milestones such as the FDA approval of several complex generic drugs. His dual role as Chief Scientific Officer and CEO enables him to seamlessly integrate scientific research with business strategy, ensuring that Amphastar remains at the forefront of pharmaceutical innovation. In his multifaceted role at Amphastar, Zhang oversees the company's overall operations, strategic direction, and scientific research initiatives. His leadership style is characterized by a hands-on approach, fostering a culture of collaboration and continuous improvement within the organization. Zhang's dedication to advancing healthcare through high-quality pharmaceuticals has not only driven Amphastar's growth but also solidified its reputation as a trusted provider in the global market. His visionary leadership continues to inspire the team at Amphastar as they work towards achieving new heights in the pharmaceutical industry.